Skip to content

Effect of Pethedin on duration of labor and type of delivery in nulliparous women

Effect of Pethedin on duration of labor and type of delivery in nulliparous women

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201407016575N5
Enrollment
90
Registered
2015-02-15
Start date
2013-04-14
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The relationship between Pethedin with the duration of labor and type of delivery in nulliparous women.

Interventions

Intervention 1: The Pethedin group received 50 mg Pethedin Intra Muscular. Intervention 2: The Placebo group received an equal volume of Normal Slaine Intra Venous.
Treatment - Drugs
The Pethedin group received 50 mg Pethedin Intra Muscular.
The Placebo group received an equal volume of Normal Slaine Intra Venous.

Sponsors

Ilam University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:18-35 years of old; nulliparous; singleton pregnancy; gestational age 38-40; without CPD; optimal care during pregnancy; blood pressure less than 140/90 mmHg; pulse 60-110; Body Mass Index 19/8-26 (kg/m) before pregnancy; intact of membrane; estimated fetal weight less than 4000 grams; exclusion criteria: Polyhydramnios; abnormal presentation; Preeclampsia; history of medical problems during and before pregnancy such as Asthma; Cardiovascular and Metabolic disease at the admission time

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Duration of labor in nulliparus women. Timepoint: Start of admission to delivery. Method of measurement: Duration of labor according to minute.;Type of delivery in nulliparous women. Timepoint: Start of admission to delivery. Method of measurement: Divided into two groups normal vaginal deliveries and cesarean section.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAshraf Direkvand-Moghadam

Ilam University of Medical Sciences

direkvand-a@medilam.ac.ir+98 84 3221 3171

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026